Preembryo Personhood: An Assessment of the President’s Council Arguments

The President’s Council on Bioethics has addressed the moral status of human preembryos in its reports on stem cell research and human therapeutic cloning. Although the Council has been criticized for being hand-picked to favor the right-to-life viewpoint concerning human preembryos, it has embraced the idea that the right-to-life position should be defended in secular terms. This is an important feature of the Council’s work, and it demonstrates a recognition of the need for genuine engagement between opposing sides in the debate over stem cell research. To promote this engagement, the Council has stated in secular terms several arguments for the personhood of human preembryos. This essay presents and critiques those arguments, and it concludes that they are unsuccessful. If the best arguments in support of the personhood of human preembryos have been presented by the Council, then there are no reasonable secular arguments in support of that view

Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)

BACKGROUND: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of cancer survival by central analysis of population-based registry data, as a metric of the effectiveness of health systems, and to inform global policy on cancer control. METHODS: Individual tumour records were submitted by 279 population-based cancer registries in 67 countries for 25·7 million adults (age 15-99 years) and 75,000 children (age 0-14 years) diagnosed with cancer during 1995-2009 and followed up to Dec 31, 2009, or later. We looked at cancers of the stomach, colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and childhood leukaemia. Standardised quality control procedures were applied; errors were corrected by the registry concerned. We estimated 5-year net survival, adjusted for background mortality in every country or region by age (single year), sex, and calendar year, and by race or ethnic origin in some countries. Estimates were age-standardised with the International Cancer Survival Standard weights. FINDINGS: 5-year survival from colon, rectal, and breast cancers has increased steadily in most developed countries. For patients diagnosed during 2005-09, survival for colon and rectal cancer reached 60% or more in 22 countries around the world; for breast cancer, 5-year survival rose to 85% or higher in 17 countries worldwide. Liver and lung cancer remain lethal in all nations: for both cancers, 5-year survival is below 20% everywhere in Europe, in the range 15-19% in North America, and as low as 7-9% in Mongolia and Thailand. Striking rises in 5-year survival from prostate cancer have occurred in many countries: survival rose by 10-20% between 1995-99 and 2005-09 in 22 countries in South America, Asia, and Europe, but survival still varies widely around the world, from less than 60% in Bulgaria and Thailand to 95% or more in Brazil, Puerto Rico, and the USA. For cervical cancer, national estimates of 5-year survival range from less than 50% to more than 70%; regional variations are much wider, and improvements between 1995-99 and 2005-09 have generally been slight. For women diagnosed with ovarian cancer in 2005-09, 5-year survival was 40% or higher only in Ecuador, the USA, and 17 countries in Asia and Europe. 5-year survival for stomach cancer in 2005-09 was high (54-58%) in Japan and South Korea, compared with less than 40% in other countries. By contrast, 5-year survival from adult leukaemia in Japan and South Korea (18-23%) is lower than in most other countries. 5-year survival from childhood acute lymphoblastic leukaemia is less than 60% in several countries, but as high as 90% in Canada and four European countries, which suggests major deficiencies in the management of a largely curable disease. INTERPRETATION: International comparison of survival trends reveals very wide differences that are likely to be attributable to differences in access to early diagnosis and optimum treatment. Continuous worldwide surveillance of cancer survival should become an indispensable source of information for cancer patients and researchers and a stimulus for politicians to improve health policy and health-care systems

Análise de agrupamento na seleção de modelos de regressão não-lineares para curvas de crescimento de ovinos cruzados Cluster analysis applied to nonlinear regression models selection to growth curves of crossed lambs

Este estudo teve como objetivo utilizar a análise de agrupamento para classificar modelos de regressão não-lineares usados para descrever a curva de crescimento de ovinos cruzados, tendo em vista os resultados de diferentes avaliadores de qualidade de ajuste. Para tanto, utilizaram-se dados de peso-idade dos seguintes cruzamentos entre raças de ovinos de corte: Dorper x Morada Nova, Dorper x Rabo Largo e Dorper x Santa Inês. Após a indicação do melhor modelo, objetivou-se ainda aplicar a técnica de identidade de modelos a fim de identificar o cruzamento mais produtivo. Foram ajustados doze modelos não-lineares, cuja qualidade de ajuste foi medida pelo coeficiente de determinação ajustado, critérios de informação de Akaike e Bayesiano, erro quadrático médio de predição e coeficiente de determinação de predição. A análise de agrupamento indicou o modelo Richards como o mais adequado para descrever as curvas de crescimento dos três grupos genéticos considerados, e os testes de identidade de modelos indicaram o cruzamento Dorper x Santa Inês como sendo o mais indicado para a pecuária local.<br>This study had the objectives to use the cluster analysis in order to classify nonlinear regression models used to describe the growth curve in relation to different quality fit evaluators. Were utilized weight-age data from the following crossbred beef lambs Dorper x Morada Nova, Dorper x Rabo Largo e Dorper x Santa Inês. After the choice of the best model, we aimed also to apply the model identity in order to identify the most efficient crossbred group. Eleven nonlinear models were used, whose fit quality was measured by determination coefficient, Akaike information criterion, Bayesian information criterion, mean quadratic error of prediction and predicted determination coefficient. The cluster analysis indicated the Richards as the best model for the three data sets, and the model identity tests revealed that the Dorper x Santa Inês crossbred group was recommend for meat production

C-Strategy: A Dynamic Adaptive Strategy for the CLONALG Algorithm

Vol. 6260The control of parameters during the execution of bioinspired algorithms is an open research area. In this paper, we propose a new parameter control strategy for the immune algorithm CLONALG. Our approach is based on reinforcement learning ideas. We focus our attention on controlling the number of clones. Our approach provides an efficient and low cost adaptive technique for parameter control. We use instances of the Travelling Salesman Problem. The results obtained are very encouraging

Incremental particle swarm-guided local search for continuous optimization

We present an algorithm that is inspired by theoretical and empirical results in social learning and swarm intelligence research. The algorithm is based on a framework that we call incremental social learning. In practical terms, the algorithm is a hybrid between a local search procedure and a particle swarm optimization algorithm with growing population size. The local search procedure provides rapid convergence to good solutions while the particle swarm algorithm enables a comprehensive exploration of the search space. We provide experimental evidence that shows that the algorithm can find good solutions very rapidly without compromising its global search capabilities. © 2008 Springer Berlin Heidelberg.SCOPUS: cp.k5th International Workshop on Hybrid Metaheuristics, HM 2008; Malaga; Spain; 8 October 2008 through 9 October 2008.info:eu-repo/semantics/publishe